BioMedomics, Inc.

BioMedomics' products diagnose critical blood disorders in minutes

  • Stage Full Product Ready
  • Industry Medical Devices and Equipment
  • Location Durham, NC, US
  • Currency USD
  • Founded October 2006
  • Employees 13
  • Website biomedomics.com

Company Summary

BioMedomics, Inc. is a point-of-care (POC) diagnostics company focused on unique, disease-specific tests and highly- advanced quantitative detection platforms. The Company has successfully developed and marketed 4 novel tests for hemoglobinopathies: Sickle SCAN®, α-Thal SCAN®, Hemo SCAN®, and Hemo SCAN® S. We are currently developing a rapid test for β-thalassemia, and a new line of rapid quantitative tests based on a novel diagnostic platform.

Team

  • Frank Wang
    CEO

    -UNC Med School Assistant Professor, Biomedical Engineering
    -General Manager of Juki, Co-Founder of BioMachines
    -Recognized Expert in Time Resolved Technology

  • Phillip Wise
    President

    -Senior Level Experience in Commercial and BD at GlaxoWellcome,
    -VP – BD and CFO at Ardent & Enhance

  • Jason Kim
    VP Product Development and Technology

    -PhD Chemistry UNC, US Naval Research Labs in POC testing
    -Multiple tests with FDA and CE Mark approval at NanoEntek

  • Larry Porter
    VP Business Development and Regulatory

    Over 40 years in Diagnostics. Past-President – LifeSign and Orion Diagnostica

  • Linxian Wu
    COO

    -President and COO of Fresenius Kabi and Fresenius Hemocare, Inc.
    -EVP and CTO of Gull Laboratories, Inc.; Director of Gen Track, Inc.

Advisors

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free